CClinicalTrials.gg
CompletedNCT01720966ALIVEUpdated Nov 10, 2015

Adhesions After Open Versus Laparoscopic Resection of Colorectal Malignancies Detected During Liver Resection

An observational study in Adhesions, sponsored by Radboud University Medical Center. Completed at 6 sites in Netherlands. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2015-11-10.

Sponsored by Radboud University Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Rationale: Adhesion formation is a frequent complication after abdominal surgery. Adhesion formation might be reduced by laparoscopic surgery, however sound evidence is lacking. Colorectal surgery would be a good clinical model to investigate adhesion formation between open and laparoscopic surgery because of the adhesion formation propensity of colorectal surgery. However, a randomized controlled study to provide direct evidence is unlikely because of large numbers of patients needed for such a trial and the difficulty to check for adhesion formation at second surgery. Therefore we investigate adhesion formation after laparoscopic and open colorectal surgery for malignancy at liver surgery for metastases.

Objective: The aim of our study is to compare the incidence of adhesions after laparoscopic versus open surgery for colorectal malignancies during liver resection for colorectal metastases.

Study design: The study is designed as a prospective observational cohort study.

Study population: All consecutive, adult patients undergoing laparotomy or laparoscopy for intended liver resection or radio frequency ablation for liver metastases of a colorectal malignancy in whom inspection of the middle and lower abdomen is possible to map adhesions.

Main study parameters/endpoints:

  • Primary endpoint is incidence of adhesions to the ventral abdominal wall around the site of the original incision.
  • Secondary endpoints are episodes of bowel obstruction between index surgery and liver surgery; total incidence of adhesions; extent of adhesions; Zühlke classification of adhesions; performance of adhesiolysis; duration of adhesiolysis; peroperative complications: enterotomy, seromuscular injury, inadvertent organ injury during adhesiolysis; postoperative complications: delayed diagnosed perforation, SAE's.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: This study is an observational study. The existence of adhesions will be assessed during laparotomy or laparoscopy for the treatment of liver metastases. The laparotomy is indicated for medical treatment and should not be enlarged solely for the assessment of adhesions nor will the operating time be influenced for this purpose.

Adhesions and peroperative complications have to be scored by the operating surgeon during or directly after surgery. The postoperative complications have to be scored during the postoperative course by the doctors on the ward. These assessments do not interfere with the treatment of the patients.

02

Conditions studied

  • Adhesions

Keywords

  • Adhesions
  • laparoscopy
  • laparotomy
  • liver resection
  • colorectal malignancy
03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 150 is below the median of 204 across 1,683 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All consecutive patients undergoing laparotomy or laparoscopy for intended liver resection or radio frequency ablation for colorectal metastases in the before mentioned centers will be assessed for eligibility. The planned number of patients will be recruited in approximately 1 year.

Inclusion criteria

  • laparotomy or laparoscopy for intended liver resection or radio frequency ablation for colorectal metastases
  • laparoscopy or laparotomy for colorectal malignancy in history
  • age ≥18 years

Exclusion criteria

Exclusion Criteria:

  • a history of abdominal surgery with a high risk of adhesions either before resection of the primary tumour or during the interval between resection of the primary tumour and liver resection. These high risk surgeries are:

    • Colorectal surgery
    • Ovarian surgery
    • Abdominal wall surgery
  • mental incompetence
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (actual)
Patient registry
No

Groups and cohorts

  • Laparoscopy

    Patients who will undergo liver resection who have a laparoscopically performed colorectal resection in history. Assignment to cohort is on intention to treat of the primary operation.

    Procedure: Liver resection

  • Laparotomy

    Patients who will undergo liver resection who have an open colorectal resection in history. Assignment to cohort is on intention to treat of the primary operation.

    Procedure: Liver resection

Interventions

  • ProcedureLiver resection

    Liver resection performed for metastatic disease from colorectal carcinoma

06

What researchers measure

Primary outcomes

  1. Incidence of adhesion to ventral abdominal wall

    To compare the incidence of adhesions to the ventral abdominal wall in patients undergoing laparotomy or laparoscopy for intended liver resection for colorectal metastases after open versus laparoscopic resection of the primary tumour.

    Time frame: peroperative (1 day)

Secondary outcomes

  1. Incidence of adhesions

    Total incidence of adhesions

    Time frame: peroperative (1 day)

  2. Extent of adhesions

    Extent of adhesions

    Time frame: peroperative (1 day)

  3. Adhesion Score

    Adhesion score according to Zühlke

    Time frame: peroperative (1 day)

  4. Adhesiolysis

    need to perform adhesiolysis

    Time frame: peroperative (1 day)

  5. Duration of adhesiolysis

    Duration of adhesiolysis in minutes

    Time frame: peroperative (1 day)

  6. Inadvertent bowel injury

    Inadvertent bowel injury made during operation

    Time frame: peroperative (1 day)

  7. Postoperative mobidity

    Incidence of predetermined postoperative complications: * mortality * incisional wound infection * abdominal sepsis * pneumonia * urinary tract infection

    Time frame: 30 days

Other outcomes

  1. Small bowel obstruction in history

    Patient has episode of small bowel obstruction in medical history

    Time frame: in history (up to 5 years preceeding second operation)

07

Study locations

6 sites
  • Radboud University Nijmegen Medical Center
    Nijmegen, Gelderland, Netherlands
  • Gelre Ziekenhuis
    Apeldoorn, Netherlands
  • Ziekenhuis Gelderse Vallei
    Ede, Netherlands
  • Maastricht University Medical Center
    Maastricht, Netherlands
  • Daniel de hoed kliniek
    Rotterdam, Netherlands
  • Maxima Medisch Centrum
    Veldhoven, Netherlands
08

References and documents

Publications

  • ten Broek RP, Strik C, Issa Y, Bleichrodt RP, van Goor H. Adhesiolysis-related morbidity in abdominal surgery. Ann Surg. 2013 Jul;258(1):98-106. doi: 10.1097/SLA.0b013e31826f4969. PubMed 23013804 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 10, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01720966
Lead sponsor
Radboud University Medical Center
Responsible party
Sponsor
First posted
Nov 2, 2012
Start date
Jan 2013
Primary completion
Oct 2015
Completion
Oct 2015
Last update
Nov 10, 2015

Study contacts

Harry P van Goor, MD, PhD
principal investigator · Radboud University Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion